This short survey is to gather preliminary information on how the SAVE trial may influence the practice patterns of providers.
The Sleep Apnea Cardiovascular Endpoints (SAVE) trial is a recent study suggesting that CPAP treatment of patients suffering from obstructive sleep apnea (OSA) does not result in cardiovascular benefits. The survey is being conducted by the editorial team at Sleep Review with no sponsor affiliation.

Take the survey here:

Your responses are completely anonymous. No personally identifiable information is captured unless you voluntarily offer personal or contact information in any of the comment fields. Additionally, your responses are combined with those of many others and summarized to further protect your anonymity. A summary of the findings may be published in Sleep Review and on